- an agent that causes alterations in perception, cognition, and mood
-
Anticholinergic
-
Scopolamine
- Acetylcholine receptor antagonist
- Side effects: Dry mouth, blurred vision, increased heart rate
- Used in motion sickness medicine
- Produced from plants like nightshade, mandrake, and stinkweed
-
Catecholaminelike
- Mixed dopamine and serotonin agonists
-
Mescaline
- Obtained from a common cactus, Peyote
- Single dose persists for 10 hours
- Not metabolized before excretion
- Produces visual hallucinations
- Normal oral dose: 5mL per Kg of body weight
-
Synthetic Amphetamine Derivatives
-
DOM, MDA, MDE, TMA
- 1-6mL produces euphoria
- Hallucinations last 6-8 hrs
- catecholamine and serotonin interactions
-
AMT, 5-MeO-DIPT
- High abuse potential, no therapeutic usefulness
- Produces hallucinations, mood elevation, insomnia
- Reuptake inhibitor of norepinephrine, dopamine, and serotonin
-
MDMA (ecstasy)
- Induces a sense of disembodiment and visual distortion
- Potent and selective serotonin neurotoxin
- Repeated use associated with sleep, mood, and anxiety disturbances, elevated impulsiveness, memory deficits, and attention problems
- Recreational use can lead to hyperthermia, tachycardia and disorientation
-
Myristicin and Elemicin
- Obtained from nutmeg
- Side effects: vomiting, nausea, tremors
- Induces feelings of unreality, confusion, impending doom, and euphoria
-
Serotoninlike Psychedelics
-
Lysergic Acid Diethylamide (LSD)
-
kinetics- taken oral 25- 300 micrograms
- 1 hour to absorb, peak at 3 hours. 6-8 hour duration of action
- metabolised in the liver
- synthesised by Albert Hoffman in 1938 from fungus
- physiological effects- increased heart rate, blood pressure, body temp, pupil size
- Psychological- alterations in perception, thinking, arousal, time ideals, visual perceptions
- MOA- acts on 5HT2a receptor
-
DMT
- MOA- partial agonist at 5HT2 receptor
- 30- 60 minute onset, peak at 1-2 hours, 3-4 hour duration
- side effects-distortion in perception, paranoia, anxiety
- LSD like effects in users
-
Bufotenine
-
serotonin agonist
- affinity for 5-HT2A
- obtained from the cutaneous glandular secretions of a toad
- MAO responsible for metabolism
-
Psilocybin
- 5-HT2A and 5-HT1A agonist
- Obtained from certain mushrooms
- Oral dose: 0.25mg per Kg of body weight
- Produces changes in mood, cognitive disturbances, visual hallucinations, and impaired ego functioning
-
Ololiuqui
- Obtained from morning glory seeds
- Side effects: Nausea, vomiting, headache, increased BP, sleepiness
- Produces distorted perception, hallucinations, confusion
-
Harmine
- Ontained from seeds of Peganum harmala
- Produces visual distortions
- Side effects: nausea, vomiting, sedation
- May have some antidepressant properties
-
BZP and TFMPP
- BZP: Norepinephrine and dopamine releasing agent
- TFMPP: Serotonergic agonist
- recreational hallucinogenics
- Side effects: agitation, anxiety, vomiting, insomnia
- Inhibit drug metabolizing enzymes in liver which may increase toxicity to other drugs
-
Glutaminergic NMDA Receptor Antagonist
-
Salvia
- Active Salvinorin A
- Kappa Opiod agonist
- short acting legal hallucinogen
- used by mexican indians for centuries
- Plant form is member of the mint family
-
Dextromethorphan
- MOA- NMDA blockade similar to Ketamine
- aids in pain relieving effects of opiods
- common ingredient in in 140 cough medicines
- Side effects include tachycardia, hypertension, agitation, and slurred speech
- causes hallucinations at high doses
- Subtopic 6
-
Ketamine
- Introduced in 1960 as anesthetic
- Similar to Phencyclidine with fewer side effects and better tolerated in relation to heart
- Better maintains blood pressure and heart rate
- Smoked 15 minutes 40% reaches blood
- Taken orally two hours
- T 1/2 of 18 hours
- 5 mg street dose
-
Phencyclidine
- Developed in 1956 as anesthetic
- Side effects include psychiatric reactions, agitation, excitement, delirium,
- MOA- noncompetitive antagonist at NMDA receptor.
- Block channel from opening and reduce the frequency at which it opens
- Psychological- removal from self and environment, unable to retain cognitive set.
- Low dose- mild agitation, euphoria, disinhibition, and excitement.
- High Dose- coma or stupor